Neovasc Inc. Preferred Stock (Total)

Preferred Stock (Total) of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Preferred Stock (Total) growth rates and interactive chart.


Highlights and Quick Summary

  • Preferred Stock (Total) for the quarter ending September 30, 2015 was $0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Preferred Stock (Total) decreased by NaN%
  • Annual Preferred Stock (Total) for 2013 was $0 (a NaN% decrease from previous year)
  • Annual Preferred Stock (Total) for 2012 was $0 (a NaN% decrease from previous year)
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Preferred Stock (Total) of Neovasc Inc.

Most recent Preferred Stock (Total)of NVCN including historical data for past 10 years.

Interactive Chart of Preferred Stock (Total) of Neovasc Inc.

Neovasc Inc. Preferred Stock (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2015 $0.0 $0.0 $0.0
2014 $0.0 $0.0 $0.0 $0.0
2013 $0.0 $0.0 $0.0 $0.0 $0.0
2012 $0.0 $0.0 $0.0 $0.0 $0.0
2011 $0.0 $0.0

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.